Fanconi anemia and DNA repair

Human Molecular Genetics

Volumn 10, Issue 20, 2001, Pages 2253-2259

  Grompe, Markus ^a   D'Andrea, Alan ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; COMPLEMENTARY DNA; FANCONI ANEMIA PROTEIN; GENE PRODUCT; NUCLEAR PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; AUTOSOMAL RECESSIVE DISORDER; BIRTH DEFECT; BONE MARROW DEPRESSION; CANCER SUSCEPTIBILITY; CELL NUCLEUS; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; CYTOLOGY; DNA CROSS LINKING; DNA DAMAGE; DNA DETERMINATION; DNA FLANKING REGION; DNA REPAIR; DNA STRAND; FANCONI ANEMIA; FEMALE; GENETIC ANALYSIS; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MEIOSIS; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW;

ANIMALIA;

EID: 0035474694     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.20.2253     Document Type: Review

References (100)

1. Familial constitutional panmyelocytopathy. Fanconi's anemia (F.A.) I. Clinical aspects
2. Hematologic abnormalities in Fanconi anemia
3. Hematologic abnormalities in Fanconi anemia: An International Fanconi Anemia Registry study
4. Fanconi's anemia and malignancies
5. Brain tumors in patients with Fanconi's anemia
6. Fanconi's anaemia and its variability
7. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents
8. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens
9. Fanconi anemia diagnosis and the diepoxybutane (DEB) test
10. Radiosensitivity in Fanconi anemia: Application to the conditioning for bone marrow transplantation
11. Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C
12. G2 chromosomal radiosensitivity in Fanconi's anemia
13. Fanconi anemia mutation causes cellular susceptibility to ambient oxygen
14. Cytotoxicity of DNA crosslinking damage and oxygen tension in Fanconi anemia fibroblasts
15. Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells
16. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia
17. Effect of oxygen tension on chromosomal aberrations in Fanconi anaemia
18. Effect of caffeine in Fanconi anemia. I. Restoration of a normal duration of G2 phase
19. G2 phase cell cycle disturbance as a manifestation of genetic cell damage
20. Modulation of the spontaneous G2 phase blockage in Fanconi anemia cells by caffeine: Differences from cells arrested by X-irradiation
21. DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function
22. Investigation of the cell cycle response of normal and Fanconi's anaemia fibroblasts to nitrogen mustard using flow cytometry
23. The cell cycle of lymphocytes in Fanconi anemia
24. Cytogenetic and flow cytometric studies of cells from patients with Fanconi's anemia
25. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1
26. Fanconi anemia C protein acts at a switch between apoptosis and necrosis in mitomycin C-induced cell death
27. Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice
28. The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-α and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily
29. Inactivation of the Fanconi anemia group C gene augments interferon-γ-induced apoptotic responses in hematopoietic cells
30. Germ cell defects and hematopoietic hypersensitivity to γ-interferon in mice with a targeted disruption of the Fanconi anemia C gene
31. Complementation analysis in Fanconi anemia: Assignment of the reference FA-H patient to group A
32. Evidence for at least eight Fanconi anemia genes
33. Positional cloning of a novel Fanconi anemia gene. FANCD2
34. Cloning of cDNAs for Fanconi's anemia by functional complementation
35. Expression cloning of a cDNA for the major Fanconi anaemia gene. FAA
36. Positional cloning of the Fanconi anaemia group A gene
37. The Fanconi anaemia group G gene FANCG is identical with XRCC9
38. The fanconi anaemia gene FANCF encodes a novel protein with homology to ROM
39. Isolation of a cDNA representing the Fanconi anemia complementation group E gene
40. Complementation group assignments in Fanconi anemia fibroblast cell lines from North America
41. Identification of two complementation groups in Fanconi anemia
42. Complementation groups: One or more per gene?
43. Fanconi anaemia complementation groups in Germany and The Netherlands. European Fanconi Anaemia Research group
44. The Ashkenazi Jewish Fanconi anemia mutation: Incidence among patients and carrier frequency in the at-risk population
45. A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews
46. Carrier frequency of the IVS4 + 4 A→T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population
47. Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa
48. Association of complementation group and mutation type with clinical outcome in fanconi anemia
49. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: An International Fanconi Anemia Registry study
50. Mutation analysis of the Fanconi anemia gene FACC
51. Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells
52. Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells
53. The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells
54. Developmental expression of the Fac gene correlates with congenital defects in Fanconi anemia patients
55. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex
56. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex
57. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA
58. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG
59. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway
60. Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system
61. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis
62. The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation
63. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner
64. Human α spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex
65. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF
66. SNX5, a new member of the sorting nexin family, binds to the Fanconi anemia complementation group A protein
67. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase
68. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2
69. Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression
70. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
71. Monoubiquitin carries a novel internalization signal that is appended to activated receptors
72. Protein regulation by monoubiquitin
73. Association of BRCA1 with Rad51 in mitotic and meiotic cells
74. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
75. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures
76. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response
77. DNA polymerase stalling, sister chromatid recombination and the BRCA genes
78. Brca1 controls homology-directed DNA repair
79. Homology-directed DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a brca1 mutation
80. Meiotic chromosomes: Integrating structure and function
81. Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres
82. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation
83. Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity
84. Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair
85. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining
86. The fidelity of double strand breaks processing is impaired in complementation groups B and D of Fanconi anemia, a genetic instability syndrome
87. Elevated homologous recombination activity in fanconi anemia fibroblasts
88. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus
89. Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients
90. Frequencies of HPRT-lymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors
91. G2/M-phase arrest and release in ataxia telangiectasia and normal cells after exposure to ionizing radiation
92. Molecular dosimetry for sister-chromatid exchange induction and cytotoxicity by monofunctional and bifunctional alkylating agents
93. Effects of alkylating agents on lymphocytes from controls and from patients with Fanconi's anemia. Studies of sister chromatid exchanges, chromosome aberrations, and kinetics of cell division
94. Frequency and distribution of sister-chromatid exchanges in a case of Fanconi's anemia
95. DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links
96. Double-strand break repair by interchromosomal recombination: Suppression of chromosomal translocation
97. Human α spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links
98. Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links
99. Damage-resistant DNA synthesis in fanconi anemia cells treated with a DNA cross-linking agent
100. Arrest of S-phase progression is impaired in Fanconi anemia cells